Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck (SCCHN)”

217 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 217 results

Very early researchEnded earlyNCT02827838
What this trial is testing

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Wake Forest University Health Sciences 17
Not applicableUnknownNCT04721184
What this trial is testing

Impact of Low Muscle Mass in HNC Treated With Immunotherapy

Who this might be right for
Head and Neck Small Cell CarcinomaSarcopenia
Institut Català d'Oncologia 120
Large-scale testing (Phase 3)Study completedNCT05802290
What this trial is testing

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Gruppo Oncologico del Nord-Ovest 124
Testing effectiveness (Phase 2)Ended earlyNCT01285635
What this trial is testing

AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
University of Michigan Rogel Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)Study completedNCT00815295
What this trial is testing

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Who this might be right for
Squamous Cell Cancer
Duke University 31
Early research (Phase 1)Study completedNCT00083057
What this trial is testing

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
National Institutes of Health Clinical Center (CC) 30
Large-scale testing (Phase 3)WithdrawnNCT03342352
What this trial is testing

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Who this might be right for
Head and Neck Cancer
Incyte Corporation
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT00939627
What this trial is testing

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT02586207
What this trial is testing

Pembrolizumab in Combination With CRT for LA-SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+4 more
Sanford Health 59
Not applicableStudy completedNCT04672772
What this trial is testing

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 531
Not applicableStudy completedNCT03880396
What this trial is testing

Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Assiut University 62
Testing effectiveness (Phase 2)Study completedNCT02289209
What this trial is testing

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Who this might be right for
Recurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck
Dan Zandberg 48
Testing effectiveness (Phase 2)Study completedNCT02101034
What this trial is testing

PD 0332991 and Cetuximab in Patients With Incurable SCCHN

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Washington University School of Medicine 96
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03174275
What this trial is testing

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellOral CancerOropharynx Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT01181401
What this trial is testing

InductionChemo-Radio-Antibody-Treatment

Who this might be right for
Squamous Cell Carcinoma of the HeadSquamous Cell Carcinoma of the Neck
Charite University, Berlin, Germany 94
Next Page